Publication: 3678

Circulating tumor DNA dynamics on front line chemotherapy with bevacizumab or cetuximab in metastatic colorectal cancer: a biomarker analysis for acquired genomic alterations in CALGB/SWOG 80405 (Alliance) randomized trial
   Google Scholar   
Citation:
J Clin Oncol vol 40 (4_suppl) abstr 193
Meeting Instance:
ASCO GI 2022
Year:
2022
Type:
Abstract
Sub type:
Poster Discussion
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
3694  
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
 
Grants:
R01 CA184843; U10 CA180821; U1 0CA180888  
Corr. Author:
 
Authors:
               
Networks:
CA011, CA824, LAPS-MN026, LAPS-NC007, LAPS-TX035   
Study
CALGB-80405
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: